scholarly article | Q13442814 |
P2093 | author name string | James L Mulshine | |
Thomas A D'Amico | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors | Q23909354 | ||
Tobacco and cancer: recent epidemiological evidence | Q23919091 | ||
Benefits and harms of CT screening for lung cancer: a systematic review | Q24600624 | ||
Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening | Q27025805 | ||
Cancer statistics, 2014 | Q27861018 | ||
Reduced lung-cancer mortality with low-dose computed tomographic screening | Q28241954 | ||
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. | Q53349399 | ||
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups | Q28269086 | ||
Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation | Q28295538 | ||
American Cancer Society lung cancer screening guidelines | Q30414481 | ||
Probability of cancer in pulmonary nodules detected on first screening CT. | Q30573941 | ||
Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force | Q31057585 | ||
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Sc | Q34308138 | ||
High prevalence of lung cancer in a surgical cohort of lung cancer patients a decade after smoking cessation | Q34668063 | ||
A risk model for lung cancer incidence | Q34966064 | ||
Results of the two incidence screenings in the National Lung Screening Trial | Q34978058 | ||
Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. | Q34990617 | ||
Modeling the mortality reduction due to computed tomography screening for lung cancer | Q35112930 | ||
Emphysema scores predict death from COPD and lung cancer. | Q36151748 | ||
Clinical practice. Lung cancer screening | Q36179045 | ||
Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study | Q37045787 | ||
A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions | Q37079386 | ||
Selection criteria for lung-cancer screening | Q37594556 | ||
The use of volumetric CT as an imaging biomarker in lung cancer. | Q37647151 | ||
Ordinal Scoring of Coronary Artery Calcifications on Low-Dose CT Scans of the Chest is Predictive of Death from Cardiovascular Disease | Q37786902 | ||
Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial. | Q38001576 | ||
Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer | Q38118426 | ||
Long-term mortality after screening for colorectal cancer | Q38139063 | ||
Radiation risk of lung cancer screening | Q38164577 | ||
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours | Q39512984 | ||
Multi-ethnic study of atherosclerosis arterial age versus framingham 10-year or lifetime cardiovascular risk | Q39563713 | ||
Lung cancer screening by spiral CT. What is the optimal target population for screening trials? | Q40620320 | ||
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules | Q43830539 | ||
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. | Q45024030 | ||
Natural history of stage I non-small cell lung cancer: implications for early detection | Q46506976 | ||
A quantitative method for estimating individual lung cancer risk. | Q46647746 | ||
Smoking cessation following CT screening for early detection of lung cancer | Q48656317 | ||
The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round. | Q50549342 | ||
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. | Q50984909 | ||
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. | Q51181963 | ||
An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. | Q51182479 | ||
CT screening for lung cancer: implication of lung biopsy recommendations. | Q51440551 | ||
Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. | Q53115741 | ||
Assessment of lung-cancer mortality reduction from CT Screening. | Q53254637 | ||
Management of lung nodules detected by volume CT scanning. | Q53321287 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lung cancer | Q47912 |
P304 | page(s) | 352-363 | |
P577 | publication date | 2014-06-27 | |
P1433 | published in | CA | Q326141 |
P1476 | title | Issues with implementing a high-quality lung cancer screening program | |
P478 | volume | 64 |
Q47643679 | A rare case of cavitary lung cancer complicated with mycotic pneumonia and bullous emphysema: A case report and review of the literature |
Q64080833 | Association between different sequences of vessel ligation during video-assisted thoracoscopic lobectomy and survival in patients with non-small cell lung cancer |
Q47094363 | Automatic Lung-RADS™ classification with a natural language processing system |
Q36162615 | Can CT Screening Give Rise to a Beneficial Stage Shift in Lung Cancer Patients? Systematic Review and Meta-Analysis |
Q57164762 | Challenges in Lung Cancer Screening in Latin America |
Q37524905 | Controlled settings for lung cancer screening: why do they matter? Considerations for referring clinicians |
Q35801394 | ESR/ERS white paper on lung cancer screening |
Q41952990 | ESR/ERS white paper on lung cancer screening. |
Q26751228 | Early detection of lung cancer |
Q38747092 | Evaluation of Promotional Materials To Promote Low-Dose Computed Tomography (LDCT) Screening to High-Risk Consumers and Health Care Providers. |
Q33877570 | Geographical Variation and Factors Associated with Non-Small Cell Lung Cancer in Manitoba. |
Q26747805 | Implementation and organization of lung cancer screening |
Q39344447 | Implementation of lung cancer CT screening in the Nordic countries |
Q42369302 | Implementing computed tomography-based lung cancer screening in the community |
Q38648029 | Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study |
Q30239798 | Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective |
Q38940816 | Lung cancer: current therapies and new targeted treatments |
Q40484642 | Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic randomized clinical trial |
Q40520301 | Polymorphisms and expression of IL-32: impact on genetic susceptibility and clinical outcome of lung cancer |
Q93271394 | Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis |
Q36486638 | Readiness of primary care clinicians to implement lung cancer screening programs |
Q47986975 | Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe |
Q26747819 | Risk factors assessment and risk prediction models in lung cancer screening candidates |
Q47138829 | Status of lung cancer screening |
Q36268128 | The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients |